General aspects and advances of nanocarriers in a view of passive or active targeting modality in cancer therapy.
Typical approaches of nanocarrier-mediated drug delivery through systemic or non-systemic administration.
Recently devised functional nanocarriers with capability for co-integration of multi-drugs or for stimuli-activatable drug delivery.